349 related articles for article (PubMed ID: 31331367)
1. The effectiveness and safety of Kami Guibi-tang for mild cognitive impairment: study protocol of a pilot, randomized, placebo-controlled, double-blind trial.
Shin HY; Kim JH; Jahng GH; Jung WS; Park SU; Ko CN; Park JM
Trials; 2019 Jul; 20(1):448. PubMed ID: 31331367
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial.
Shin HY; Kim HR; Jahng GH; Jin C; Kwon S; Cho SY; Park SU; Jung WS; Moon SK; Ko CN; Park JM
BMC Complement Med Ther; 2021 Oct; 21(1):251. PubMed ID: 34620151
[TBL] [Abstract][Full Text] [Related]
3. Effects of Kami Guibi-tang in patients with mild cognitive impairment: study protocol for a phase III, randomized, double-blind, and placebo-controlled trial.
Shin HY; Yim TB; Heo HM; Jahng GH; Kwon S; Cho SY; Park SU; Jung WS; Moon SK; Ko CN; Park JM
BMC Complement Med Ther; 2022 Dec; 22(1):318. PubMed ID: 36461035
[TBL] [Abstract][Full Text] [Related]
4. Effect of Kami Guibi-tang (KGT) in elderly subjects with insomnia: a study protocol from a single center, randomized, double-blind, placebo-controlled trial.
Lee KH; Lee HG; Kwon S; Park SU; Jung WS; Moon SK; Park JM; Ko CN; Cho SY
BMC Complement Med Ther; 2023 Oct; 23(1):375. PubMed ID: 37872506
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Kami Guibi-tang as an Add-On Therapy to Acetylcholinesterase Inhibitor for Cognitive Function in Mild Alzheimer's Disease: A Pilot Study.
Kim HR; Shin HY; Yim TB; Jahng GH; Jin C; Kwon S; Cho SY; Park SU; Jung WS; Moon SK; Ko CN; Park JM
Evid Based Complement Alternat Med; 2023; 2023():4846770. PubMed ID: 36756039
[TBL] [Abstract][Full Text] [Related]
6. Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment.
Steiner GZ; Bensoussan A; Liu J; Hohenberg MI; Chang DH
Trials; 2018 Sep; 19(1):522. PubMed ID: 30253809
[TBL] [Abstract][Full Text] [Related]
7. Treatment evaluation of Kami Guibi-tang on participants with amnestic mild cognitive impairment using magnetic resonance imaging on brain metabolites, gamma-aminobutyric acid, and cerebral blood flow.
Cho SY; Kwon S; Shin HY; Kim HR; Kim JH; Park S; Ryu CW; Park JM; Edden RAE; Jahng GH
J Appl Clin Med Phys; 2021 Nov; 22(11):151-164. PubMed ID: 34633758
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Yi-Zhi-An-Shen granules on cognition and sleep quality in older adults with amnestic mild cognitive impairment: protocol for a randomized, double-blind, placebo-controlled trial.
Yue S; He T; Li B; Qu Y; Peng H; Chen J; Lei M; Chen C; Wu W
Trials; 2019 Aug; 20(1):518. PubMed ID: 31429790
[TBL] [Abstract][Full Text] [Related]
9. Combination of acupuncture and Chinese herbal formula for elderly adults with mild cognitive impairment: protocol for a randomized controlled trial.
Chen Y; Zhang W; Wu H; Lao L; Xu J; Xu S
Trials; 2019 Feb; 20(1):117. PubMed ID: 30744676
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of Chinese medicine Bushen Capsule on cognition and brain activity in patients with amnestic mild cognitive impairment.
Zhang J; Yang C; Wei D; Li H; Leung EL; Deng Q; Liu Z; Fan XX; Zhang Z
Pharmacol Res; 2019 Aug; 146():104319. PubMed ID: 31220560
[TBL] [Abstract][Full Text] [Related]
11. Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: a randomized, double-blind and parallel-controlled trial.
Miao YC; Tian JZ; Shi J; Mao M
Zhong Xi Yi Jie He Xue Bao; 2012 Apr; 10(4):390-7. PubMed ID: 22500712
[TBL] [Abstract][Full Text] [Related]
12. Effect of cognitive training on episodic memory retrieval in amnestic mild cognitive impairment patients: study protocol for a clinical randomized controlled trial.
Zhang K; Wang J; Peng G; Liu P; He F; Zhu Z; Luo B
Trials; 2019 Jan; 20(1):26. PubMed ID: 30621794
[TBL] [Abstract][Full Text] [Related]
13. Neurocircuitry of acupuncture effect on cognitive improvement in patients with mild cognitive impairment using magnetic resonance imaging: a study protocol for a randomized controlled trial.
Suh HW; Kim J; Kwon O; Cho SH; Kim JW; Kwak HY; Kim Y; Lee KM; Chung SY; Lee JH
Trials; 2019 May; 20(1):310. PubMed ID: 31146774
[TBL] [Abstract][Full Text] [Related]
14. The efficacy and safety of Danggui-Sayuk-Ga-Osuyu-Saenggang-tang on Korean patients with cold hypersensitivity in the hands: study protocol for a pilot, double-blind, randomized, placebo-controlled, parallel-group clinical trial.
Ko Y; Go HY; Cho YY; Shin JH; Kim TH; Choi DJ; Lee JM; Jang JB; Song YK; Ko SG; Sun SH; Jeon CY
Trials; 2017 Jun; 18(1):268. PubMed ID: 28595610
[TBL] [Abstract][Full Text] [Related]
15. Effects of electroacupuncture combined with computer-based cognitive rehabilitation on mild cognitive impairment: study protocol for a pilot randomized controlled trial.
Kim JH; Han JY; Park GC; Lee JS
Trials; 2019 Aug; 20(1):478. PubMed ID: 31382998
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of Yi Shen Fang granules in elderly people with MCI: study protocol for a multicentre, randomized, double-blind, parallel-group, controlled trial.
Sha Z; Zhao Z; Li N; Xiao S; Li O; Zhang J; Li Z; Xu J
BMC Complement Med Ther; 2023 Apr; 23(1):101. PubMed ID: 37013520
[TBL] [Abstract][Full Text] [Related]
17. IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia.
Kile S; Au W; Parise C; Rose K; Donnel T; Hankins A; Chan M; Ghassemi A
J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):106-112. PubMed ID: 26420886
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of Jujadokseo-hwan for memory deficit (amnesia) in mild neurocognitive disorder: A protocol for randomized, double-blind, placebo-controlled, parallel-group, multicenter clinical trial.
Jeong JH; Lee JY; Kim JY; Seo YK; Kang WC; Kang HW; Park SJ; Jang HK; Park YC; Jung IC
Medicine (Baltimore); 2020 Feb; 99(8):e19231. PubMed ID: 32080123
[TBL] [Abstract][Full Text] [Related]
19. A proof of concept phase II study with the PDE-4 inhibitor roflumilast in patients with mild cognitive impairment or mild Alzheimer's disease dementia (ROMEMA): study protocol of a double-blind, randomized, placebo-controlled, between-subjects trial.
Possemis N; Verhey F; Prickaerts J; Blokland A; Ramakers I
Trials; 2024 Mar; 25(1):162. PubMed ID: 38438923
[TBL] [Abstract][Full Text] [Related]
20. A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI.
Peters O; Lorenz D; Fesche A; Schmidtke K; Hüll M; Perneczky R; Rüther E; Möller HJ; Jessen F; Maier W; Kornhuber J; Jahn H; Luckhaus C; Gertz HJ; Schröder J; Pantel J; Teipel S; Wellek S; Frölich L; Heuser I
J Nutr Health Aging; 2012; 16(6):544-8. PubMed ID: 22659994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
